March 9, 2022 6:03 AM 3 seconds read

Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY

by Hal Lindon Benzinga Editor
Follow
Comments
Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY
CMMB Logo
CMMBChemomab Therapeutics Ltd
$1.09-3.54%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum65.96
Growth-
Quality-
Value-
Price Trend
Short
Medium
Long
Overview
Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Date
▲▼
ticker
▲▼
name
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Click to see more Earnings updates
Posted In:
EarningsNews

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved